Sumitomo Life Insurance Co. decreased its position in The Allstate Co. (NYSE:ALL – Free Report) by 3.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,373 shares of the insurance provider’s stock after selling 194 shares during the period. Sumitomo Life Insurance Co.’s holdings in Allstate were worth $1,229,000 at the end of the most recent quarter.
A number of other institutional investors have also bought and sold shares of the company. State Street Corp boosted its position in shares of Allstate by 1.1% during the 3rd quarter. State Street Corp now owns 11,496,306 shares of the insurance provider’s stock worth $2,190,758,000 after purchasing an additional 126,922 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Allstate by 1.2% in the third quarter. Geode Capital Management LLC now owns 6,228,581 shares of the insurance provider’s stock worth $1,178,164,000 after acquiring an additional 74,537 shares in the last quarter. Allspring Global Investments Holdings LLC grew its stake in Allstate by 18.7% in the third quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider’s stock valued at $569,114,000 after acquiring an additional 472,040 shares during the period. Raymond James & Associates raised its position in shares of Allstate by 10.6% during the third quarter. Raymond James & Associates now owns 1,517,800 shares of the insurance provider’s stock worth $287,851,000 after purchasing an additional 145,986 shares during the period. Finally, Pathway Financial Advisers LLC lifted its holdings in shares of Allstate by 18,472.5% in the 3rd quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock worth $199,642,000 after purchasing an additional 1,047,019 shares in the last quarter. Institutional investors own 76.47% of the company’s stock.
Analysts Set New Price Targets
Several research analysts have weighed in on the stock. UBS Group upped their price objective on shares of Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, November 4th. JPMorgan Chase & Co. raised their price target on shares of Allstate from $205.00 to $207.00 and gave the company an “overweight” rating in a research report on Thursday, October 10th. Bank of America boosted their price objective on Allstate from $216.00 to $233.00 and gave the stock a “buy” rating in a report on Friday, October 18th. BMO Capital Markets lifted their target price on Allstate from $205.00 to $214.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. Finally, Jefferies Financial Group increased their price target on Allstate from $231.00 to $267.00 and gave the company a “buy” rating in a research report on Friday, November 8th. One analyst has rated the stock with a sell rating, one has issued a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Allstate currently has a consensus rating of “Moderate Buy” and a consensus price target of $218.13.
Allstate Price Performance
Shares of ALL opened at $191.10 on Thursday. The company has a market capitalization of $50.60 billion, a P/E ratio of 12.38, a price-to-earnings-growth ratio of 1.41 and a beta of 0.52. The Allstate Co. has a twelve month low of $153.42 and a twelve month high of $209.88. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.43. The firm has a 50 day moving average of $194.46 and a 200 day moving average of $188.07.
Allstate (NYSE:ALL – Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.20 by $1.71. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The firm had revenue of $16.63 billion for the quarter, compared to the consensus estimate of $14.57 billion. During the same quarter last year, the firm posted $0.81 EPS. The business’s quarterly revenue was up 14.7% compared to the same quarter last year. As a group, equities research analysts anticipate that The Allstate Co. will post 16.83 earnings per share for the current fiscal year.
Allstate Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th were paid a dividend of $0.92 per share. The ex-dividend date of this dividend was Friday, November 29th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 1.93%. Allstate’s dividend payout ratio is currently 23.83%.
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Stories
- Five stocks we like better than Allstate
- The 3 Best Fintech Stocks to Buy Now
- Coinbase Gains Momentum on App Store—What It Means for the Stock
- What is the Nasdaq? Complete Overview with History
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- Technology Stocks Explained: Here’s What to Know About Tech
- 3 Steel Stocks Soaring After Tariff Announcements
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.